These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9467792)

  • 1. Overview of potential treatment medications for cocaine dependence.
    McCance EF
    NIDA Res Monogr; 1997; 175():36-72. PubMed ID: 9467792
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic approaches to the treatment of cocaine dependence.
    Taylor WA; Gold MS
    West J Med; 1990 May; 152(5):573-7. PubMed ID: 1971975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cocaine abuse and dependence.
    Mendelson JH; Mello NK
    N Engl J Med; 1996 Apr; 334(15):965-72. PubMed ID: 8596599
    [No Abstract]   [Full Text] [Related]  

  • 4. The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.
    Cacciola JS; Alterman AI; O'Brien CP; McLellan AT
    NIDA Res Monogr; 1997; 175():182-91. PubMed ID: 9467798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions.
    Crosby RD; Halikas JA; Carlson G
    J Addict Dis; 1991; 10(4):13-30. PubMed ID: 1685672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research.
    Kreek MJ
    NIDA Res Monogr; 1997; 175():5-35. PubMed ID: 9467791
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment.
    Ellinwood EH; Lee TH
    NIDA Res Monogr; 1997; 175():192-207. PubMed ID: 9467799
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome measurement considerations: pharmacological treatments for substance abuse.
    Moras K
    NIDA Res Monogr; 1997; 175():118-36. PubMed ID: 9467795
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials.
    Carroll KM; Nich C; Rounsaville BJ
    NIDA Res Monogr; 1997; 175():137-57. PubMed ID: 9467796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    Toll L; Berzetei-Gurske IP; Polgar WE; Brandt SR; Adapa ID; Rodriguez L; Schwartz RW; Haggart D; O'Brien A; White A; Kennedy JM; Craymer K; Farrington L; Auh JS
    NIDA Res Monogr; 1998 Mar; 178():440-66. PubMed ID: 9686407
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment effectiveness score as an outcome measure in clinical trials.
    Ling W; Shoptaw S; Wesson D; Rawson RA; Compton M; Klett CJ
    NIDA Res Monogr; 1997; 175():208-20. PubMed ID: 9467800
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis.
    Jones RT
    NIDA Res Monogr; 1997; 175():221-34. PubMed ID: 9467801
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy for adolescents with psychoactive substance use disorders.
    Kaminer Y
    NIDA Res Monogr; 1995; 156():291-324. PubMed ID: 8594475
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective.
    Nunes EV
    NIDA Res Monogr; 1997; 175():73-95. PubMed ID: 9467793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trail of multiple treatment agents for cocaine dependence: a placebo-control; elimination study.
    Tennant F
    NIDA Res Monogr; 1990; 105():512-3. PubMed ID: 1876104
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A laboratory model for evaluating potential treatment medications in humans.
    Fischman MW; Foltin RW
    NIDA Res Monogr; 1992; 119():165-9. PubMed ID: 1435973
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of clinical trials with new medications for cocaine dependence and abuse.
    Kiev A
    NIDA Res Monogr; 1997; 175():96-117. PubMed ID: 9467794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic management of relapse prevention in addictive disorders.
    Sofuoglu M; Kosten TR
    Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative urine levels of cocaine and other substances of abuse.
    Wilkins JN
    NIDA Res Monogr; 1997; 175():235-52. PubMed ID: 9467802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.